April 2005

Available Issues

April 2005

The Electronic Sarcoma Update Newsletter, Vol. 2, No. 2

Each of the words or phrases that are underlined and in a bold blue type in ESUN are hyperlinks to websites, documents or articles. Each title in the table of contents, In This Issue, is a link to the specific article. All the external hyperlinks appearing in ESUN were valid when the issue of ESUN was published. If you find any broken links, please send us a note about them. The document hyperlinks typically open PDF documents, so you should have the Adobe Acrobat Reader installed on your system in order to read them.

In This Issue

Feature Articles

Editorial

Observations influenced by Sandy Dennis

Malignant Fibrous Histiocytoma (MFH)

Dr. Morris presents an up-to-date overview of malignant fibrous histiocytoma (MFH) which is considered the most common soft tissue sarcoma of adult life. Her article contains an extensive set of references. This is another in our series of Bridge Articles.

From Easter Island Soil to Treating Sarcoma—Rapamycin Derivatives

Danny McGurl reviews some exciting work with mTOR inhibitors.

An Update on Planet Cancer

Heidi Adams presents some interesting data on young adults and cancer as she updates us on Planet Cancer.

An Update on the Abigail Alliance for Better Access to Developmental Drug

Frank Burroughs shows how effective small organizations can be.

The State of Sarcoma Advocacy

Deborah Buks ends her assessment of sarcoma advocacy with a "to do" list for all of us to consider.

Regular Columns

Clinical Trial News

A number of clinical trials that are either directed at MFH patients or that are open to them and other sarcoma patients are described as well as some non-MFH trials.

Research Corner

A range of new research results are reported, including some relating to MFH.

Our Initiatives

Updates on both the vaccine-based sarcoma research at the University of Michigan and our Team Sarcoma 2005 participation in Cycle Zydeco are given.

General Information

Disclaimer

Editorial Advisory Board and Editorial Staff

Registering to Receive Notifications About ESUN

Send us a note containing your e-mail address if you would like to receive a note when the next issue of ESUN is published.

Topics and Feedback

Please send us your recommendations for topics that you would like to see covered in ESUN as well as any other comments or feedback that can be useful to us. We also welcome contributions of essays and articles that are relevant to ESUN and its intended audience

Disclaimer

Information in ESUN and on the The Initiative's website is provided on an "as is" basis for general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are familiar with your individual medical needs. We caution readers and internet users to take care when using “medical advice” obtained on the web or in newsletters such as this. If you are concerned about your medical condition or that of a family member, loved one, or friend, consult a physician. Although we carefully review our content, The Initiative cannot guarantee nor take responsibility for the medical accuracy of documents we publish, nor can it assume any liability for the content of the various websites that we link to or that are linked to The Initiative's website. We believe the information on our website and in ESUN provides you with a starting point for a discussion with your physician who can give you his/her opinion about it.

(AMDG/SJBPFU)